Health Analytics | AI Diagnostics

Turning terabytes of clinical data into sub‑second, life‑saving insights—HIPAA‑secure, FDA‑ready

The global market for AI‑driven diagnostics is already $1.59 billion (2024) and growing 22.4 % CAGR (Grand View Research). Yet diagnostic errors still cost the U.S. system $100 billion+ a year and harm hundreds of thousands of patients (NCBI). Studies show AI can boost cancer‑detection rates 20 % when paired with clinicians (Health), and the FDA has now cleared 1,016 AI/ML medical devices (U.S. Food and Drug Administration), signaling mainstream momentum—if health systems can deploy safely and at scale.

Our promise: VarenyaZ fuses real‑time data platforms, explainable ML, and rigorous validation so your care teams diagnose faster, miss less, and stay fully compliant.